| abstract |
Pharmaceutical composition containing the thermo-sensitive polymer produced and marketed under the tradename EG56, corresponding to Bis-Methoxy PEG-13 PEG-438/PPG-110 SMDI Copolymer, and glycyrrhizin and/or its derivatives, in particular its active part without sugar, the glycyrrhetinic acid, as active principle, for the preparation of anti-inflammatory products in stable aqueous solution both for ophthalmic and nasal/oral use, in the technical form of spray or drops for disinfecting nasal and mouth cavities. |